Search research articles
Contact Us
Filters
Showing results (61-70 of 188) with videos related to
Page
of 19
Sort By:
Journal of Translational Medicine
|
July 16, 2010
Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032
Jill C Rubinstein, Mario Sznol, Anna C Pavlick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2011
Plasma markers for identifying patients with metastatic melanoma
Harriet M Kluger, Kathleen Hoyt, Antonella Bacchiocchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2005
Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation
Douglas H Thamm, Ilene D Kurzman, Ivan King, et al.
Pigment Cell & Melanoma Research
|
February 13, 2010
PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells
Ruth Halaban, Wengeng Zhang, Antonella Bacchiocchi, et al.
JAAD International
|
May 30, 2023
Evaluating the medical management of locally advanced and metastatic basal cell carcinoma: A single institutional retrospective analysis investigating efficacy, safety, and tolerability
Annika Belzer, Jolanta Pach, Ryland D Mortlock, et al.
Pigment Cell & Melanoma Research
|
July 29, 2024
Causes of death and patterns of metastatic disease at the end of life for patients with advanced melanoma in the immunotherapy era
Daniel Y Lee, Madeline McNamara, Alexander Yang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
January 2, 2007
A clinical development paradigm for cancer vaccines and related biologics
Axel Hoos, Giorgio Parmiani, Kristen Hege, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2020
Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I Study
Dmitriy Zamarin, Omid Hamid, Asha Nayak-Kapoor, et al.
Genome Research
|
June 4, 2009
Genome-wide screen of promoter methylation identifies novel markers in melanoma
Yasuo Koga, Mattia Pelizzola, Elaine Cheng, et al.
Immunological Reviews
|
July 26, 2023
CD4 T cells and toxicity from immune checkpoint blockade
Noah Earland, Wubing Zhang, Abul Usmani, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 188) with videos related to
Sort By:
Page
of 19
Journal of Translational Medicine
|
July 16, 2010
Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032
Jill C Rubinstein, Mario Sznol, Anna C Pavlick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2011
Plasma markers for identifying patients with metastatic melanoma
Harriet M Kluger, Kathleen Hoyt, Antonella Bacchiocchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2005
Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation
Douglas H Thamm, Ilene D Kurzman, Ivan King, et al.
Pigment Cell & Melanoma Research
|
February 13, 2010
PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells
Ruth Halaban, Wengeng Zhang, Antonella Bacchiocchi, et al.
JAAD International
|
May 30, 2023
Evaluating the medical management of locally advanced and metastatic basal cell carcinoma: A single institutional retrospective analysis investigating efficacy, safety, and tolerability
Annika Belzer, Jolanta Pach, Ryland D Mortlock, et al.
Pigment Cell & Melanoma Research
|
July 29, 2024
Causes of death and patterns of metastatic disease at the end of life for patients with advanced melanoma in the immunotherapy era
Daniel Y Lee, Madeline McNamara, Alexander Yang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
January 2, 2007
A clinical development paradigm for cancer vaccines and related biologics
Axel Hoos, Giorgio Parmiani, Kristen Hege, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2020
Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I Study
Dmitriy Zamarin, Omid Hamid, Asha Nayak-Kapoor, et al.
Genome Research
|
June 4, 2009
Genome-wide screen of promoter methylation identifies novel markers in melanoma
Yasuo Koga, Mattia Pelizzola, Elaine Cheng, et al.
Immunological Reviews
|
July 26, 2023
CD4 T cells and toxicity from immune checkpoint blockade
Noah Earland, Wubing Zhang, Abul Usmani, et al.
Page
of 19